The transcription factor HBP1 promotes ferroptosis in tumor cells by regulating the UHRF1-CDO1 axis
暂无分享,去创建一个
Yue Zhou | Wei Jiang | Hui Li | Xiaowei Zhang | Yuning Cheng | Jiyin Wang | Ruixiang Yang | Zhe Yang | Shujie Wang | Tongjia Zhang
[1] Jing Wang,et al. Discovery of a Potent Glutathione Peroxidase 4 Inhibitor as a Selective Ferroptosis Inducer. , 2021, Journal of medicinal chemistry.
[2] Yixian Zhou,et al. Application of glutathione depletion in cancer therapy: Enhanced ROS-based therapy, ferroptosis, and chemotherapy. , 2021, Biomaterials.
[3] Yanli Yan,et al. Silencing UHRF1 Enhances Radiosensitivity of Esophageal Squamous Cell Carcinoma by Inhibiting the PI3K/Akt/mTOR Signaling Pathway , 2021, Cancer management and research.
[4] Cuijun Deng,et al. The potential application of nanomaterials for ferroptosis-based cancer therapy , 2021, Biomedical materials.
[5] Yujuan Liu,et al. HBP1-mediated transcriptional repression of AFP inhibits hepatoma progression , 2021, Journal of experimental & clinical cancer research : CR.
[6] C. Thompson,et al. Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis , 2020, Proceedings of the National Academy of Sciences.
[7] D. Klionsky,et al. Ferroptosis: machinery and regulation , 2020, Autophagy.
[8] Shouping Xu,et al. Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin , 2020, Journal of cellular physiology.
[9] Haitao Zhu,et al. Branched-chain amino acid aminotransferase 2 regulates ferroptotic cell death in cancer cells , 2020, Cell Death & Differentiation.
[10] T. Vanden Berghe,et al. Targeting Ferroptosis to Iron Out Cancer. , 2019, Cancer cell.
[11] Z. Dai,et al. Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer. , 2019, Chemical Society reviews.
[12] J. Asara,et al. Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer , 2018, bioRxiv.
[13] Xiaoyuan Chen,et al. Fenton-Reaction-Acceleratable Magnetic Nanoparticles for Ferroptosis Therapy of Orthotopic Brain Tumors. , 2018, ACS nano.
[14] Chang-qing Yang,et al. UHRF1 mediates cell migration and invasion of gastric cancer , 2018, Bioscience reports.
[15] Wei Li,et al. BAP1 links metabolic regulation of ferroptosis to tumor suppression , 2018, Nature Cell Biology.
[16] Juyoung Yoon,et al. Supramolecular photosensitizers rejuvenate photodynamic therapy. , 2018, Chemical Society reviews.
[17] Qiaojun He,et al. The Role of Ferroptosis in Cancer Development and Treatment Response , 2018, Front. Pharmacol..
[18] J. Yu,et al. Cysteine Dioxygenase 1 Mediates Erastin-Induced Ferroptosis in Human Gastric Cancer Cells1 , 2017, Neoplasia.
[19] B. Stockwell,et al. Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease , 2017, Cell.
[20] Wei Jiang,et al. A positive feedback loop between Pim-1 kinase and HBP1 transcription factor contributes to hydrogen peroxide-induced premature senescence and apoptosis , 2017, Journal of Biological Chemistry.
[21] Xufeng Chen,et al. Uhrf1 controls the self-renewal versus differentiation of hematopoietic stem cells by epigenetically regulating the cell-division modes , 2016, Proceedings of the National Academy of Sciences.
[22] K. Yamashita,et al. Promoter DNA methylation of CDO1 gene and its clinical significance in esophageal squamous cell carcinoma. , 2016, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[23] Yifan Chen,et al. HBP1-mediated Regulation of p21 Protein through the Mdm2/p53 and TCF4/EZH2 Pathways and Its Impact on Cell Senescence and Tumorigenesis , 2016, The Journal of Biological Chemistry.
[24] Shu Yang,et al. UHRF1 overexpression is involved in cell proliferation and biochemical recurrence in prostate cancer after radical prostatectomy , 2016, Journal of experimental & clinical cancer research : CR.
[25] W. Greenhalf,et al. UHRF1 regulation of the Keap1–Nrf2 pathway in pancreatic cancer contributes to oncogenesis , 2015, The Journal of pathology.
[26] Xian‐Zheng Zhang,et al. A multifunctional metal-organic framework based tumor targeting drug delivery system for cancer therapy. , 2015, Nanoscale.
[27] Ji-Hee Kim,et al. Epigenetic regulation of the novel tumor suppressor cysteine dioxygenase 1 in esophageal squamous cell carcinoma , 2015, Tumor Biology.
[28] M. Conrad,et al. Glutathione peroxidase 4 (Gpx4) and ferroptosis: what's so special about it? , 2015, Molecular & cellular oncology.
[29] Yiran Huang,et al. Epigenetic repression of regulator of G‐protein signaling 2 by ubiquitin‐like with PHD and ring‐finger domain 1 promotes bladder cancer progression , 2015, The FEBS journal.
[30] B. Chauffert,et al. Iron‐dependent cell death of hepatocellular carcinoma cells exposed to sorafenib , 2013, International journal of cancer.
[31] Jiwei Cui,et al. One-Step Assembly of Coordination Complexes for Versatile Film and Particle Engineering , 2013, Science.
[32] J. Herman,et al. Frequent Inactivation of Cysteine Dioxygenase Type 1 Contributes to Survival of Breast Cancer Cells and Resistance to Anthracyclines , 2013, Clinical Cancer Research.
[33] J. Wong,et al. UHRF1 targets DNMT1 for DNA methylation through cooperative binding of hemi-methylated DNA and methylated H3K9 , 2013, Nature Communications.
[34] H. Ju,et al. Diagnostic and prognostic value of plasma and tissue ubiquitin‐like, containing PHD and RING finger domains 1 in breast cancer patients , 2013, Cancer science.
[35] A. Yee,et al. HBP1-Mediated Transcriptional Regulation of DNA Methyltransferase 1 and Its Impact on Cell Senescence , 2012, Molecular and Cellular Biology.
[36] M. Shirakawa,et al. Recognition of modification status on a histone H3 tail by linked histone reader modules of the epigenetic regulator UHRF1 , 2012, Proceedings of the National Academy of Sciences.
[37] Juna Lee,et al. Cysteine Dioxygenase 1 Is a Tumor Suppressor Gene Silenced by Promoter Methylation in Multiple Human Cancers , 2012, PloS one.
[38] A. Yee,et al. Transcriptional factor HBP1 targets P16INK4A, upregulating its expression and consequently is involved in Ras-induced premature senescence , 2010, Oncogene.
[39] Peter Fratzl,et al. Iron-Clad Fibers: A Metal-Based Biological Strategy for Hard Flexible Coatings , 2010, Science.
[40] Colin J. Daniel,et al. The Tumor Suppressor Protein HBP1 Is a Novel c-Myc-binding Protein That Negatively Regulates c-Myc Transcriptional Activity* , 2009, The Journal of Biological Chemistry.
[41] J. Dominy,et al. Cysteine dioxygenase: a robust system for regulation of cellular cysteine levels , 2009, Amino Acids.
[42] K. Mitsuya,et al. The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA , 2007, Nature.
[43] S. Jacobsen,et al. UHRF1 Plays a Role in Maintaining DNA Methylation in Mammalian Cells , 2007, Science.
[44] M. Maroney,et al. Cysteine dioxygenase: structure and mechanism. , 2007, Chemical communications.
[45] M. McDevitt,et al. The HBP1 Transcriptional Repressor Participates in RAS-Induced Premature Senescence , 2006, Molecular and Cellular Biology.
[46] K. Eric Paulson,et al. HBP1 Repression of the p47phox Gene: Cell Cycle Regulation via the NADPH Oxidase , 2004, Molecular and Cellular Biology.
[47] G. Austin,et al. Cloning and expression of human HBP1, a high mobility group protein that enhances myeloperoxidase (MPO) promoter activity , 2001, Leukemia.
[48] Hui Zhang,et al. Involvement of Retinoblastoma Protein and HBP1 in Histone H10 Gene Expression , 2000, Molecular and Cellular Biology.
[49] A. Gartel,et al. Activation and repression of p21WAF1/CIP1 transcription by RB binding proteins , 1998, Oncogene.